You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

paclitaxel

Showing 51 - 75 of 1,742
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peritoneal Carcinomatosis, Peritoneal Tumors, Ovarian Cancer Trial run by the National Cancer Institute (NCI) (Paclitaxel,

Not yet recruiting
  • Peritoneal Carcinomatosis
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

NSCLC Trial in United States (Napabucasin, Paclitaxel)

Terminated
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Beverly Hills, California
  • +4 more
Apr 4, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Nov 8, 2022

HER2-positive Breast Cancer Trial in Philadelphia (Atezolizumab, Paclitaxel, Trastuzumab)

Suspended
  • HER2-positive Breast Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 5, 2022

Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

Completed
  • Refractory Cancer
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Gynecologic Malignancies Trial in Cleveland (Paclitaxel, Carboplatin)

Terminated
Has Results
  • Gynecologic Malignancies
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jun 29, 2022

Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

Not yet recruiting
  • Untreated Advanced or Recurrent Thymic Carcinomas
  • Chuo, Tokyo, Japan
    National Cancer Center Hospital
Apr 16, 2023

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),

Not yet recruiting
  • Locally Advanced Unresectable Esophageal Squamous Carcinoma
  • Docetaxel for Injection (Albumin-bound)
  • +4 more
  • Jinan, Shandong, China
  • +1 more
Nov 16, 2023

Ovarian Cancer, Relapsed or Refractory, Chiauranib Trial in Shanghai (chiauranib, Placebo, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • +3 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 7, 2022

Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the

Active, not recruiting
Has Results
  • Human Papilloma Virus Infection
  • +3 more
  • paclitaxel albumin-stabilized nanoparticle formulation
  • +8 more
  • Chicago, Illinois
    University of Chicago
Mar 2, 2022

Early Stage Breast Cancer Trial in United States (Paclitaxel, Neulasta)

Completed
Has Results
  • Early Stage Breast Cancer
  • Boston, Massachusetts
  • +3 more
Apr 11, 2022

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
Jun 13, 2022

Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological

Completed
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
  • Stage IV Non-Small Cell Lung Cancer AJCC v7
  • Laboratory Biomarker Analysis
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 14, 2022

Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)

Not yet recruiting
  • Chemotherapy
  • Radiation Therapy
  • Fuzhou, China
    Fujian Medical University Union Hospital
Apr 6, 2023

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,

Withdrawn
  • Triple Negative Breast Cancer
  • +4 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 2, 2022

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Jinan, Qingdao, Yantai (Serplulimab, Lenvatinib,

Not yet recruiting
  • Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
  • Jinan, Shandong, China
  • +5 more
Oct 16, 2022

NSCLC Trial (Pembrolizumab, Paclitaxel, Nab-paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Pembrolizumab
  • +4 more
  • (no location specified)
Jan 20, 2022

Ovarian Carcinoma Trial (Paclitaxel, Carboplatin)

Completed
  • Ovarian Carcinoma
  • (no location specified)
Apr 7, 2022

Urothelial Carcinoma Trial in Amsterdam (Tremelimumab, Durvalumab, Paclitaxel)

Active, not recruiting
  • Urothelial Carcinoma
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek Ziekenhuis
Jul 7, 2022

HPV-Negative Squamous Cell Carcinoma Trial in Chicago (Paclitaxel, Carboplatin, Cetuximab)

Not yet recruiting
  • HPV-Negative Squamous Cell Carcinoma
  • Paclitaxel
  • +6 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Aug 16, 2023

Efficacy and Safety Trial in Zhejiang (pegylated liposomal doxorubicin, paclitaxel, Carboplatin)

Active, not recruiting
  • Efficacy and Safety
  • pegylated liposomal doxorubicin
  • +2 more
  • Zhejiang, Hangzhou, China
    Women's Hospital School Of Medicine Zhejiang University
Jul 14, 2022

Predictive Factors and Biological Imaging of Response to

Completed
  • Metastatic
  • Breast Cancer
  • Bordeaux, France
  • +18 more
Jan 25, 2023

Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Carboplatin, Pemetrexed, Paclitaxel)

Recruiting
  • Lung Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 24, 2023

Gestational Trophoblastic Tumors Trial in Hangzhou (Etoposide, actinomycin D, methotrexate)

Recruiting
  • Gestational Trophoblastic Neoplasms
  • Hangzhou, Zhejiang, China
    Weiguo Lv
Jun 2, 2022